Given the growing number of patients receiving direct oral anticoagulant (DOAC), patients
requiring rapid neutralization is also increasing in case of major bleedings or urgent …

Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in
patients with acute ischaemic stroke — as Page 1 1 www.journals.viamedica.pl/neurologia_neurochirurgia_polska …

Direct Oral Anticoagulants: An Update on Monitoring and Antidotes for the Perioperative
Physician | Current Anesthesiology Reports Skip to main content SpringerLink Account …

Key questions in bleeding management are “Why does my patient bleed?” and “How to fix
it?” To answer the first question, the high negative predictive value of viscoelastic testing can …

Objective: To verify the incidence of bleeding events in patients on ongoing anticoagulant
treatment in the real world and compare the results of different reversal or repletion …

The optimum treatment for acute ischaemic stroke in patients receiving active
anticoagulation, ie with effective levels of anticoagulant activity, which most commonly …

Dabigatran, a reversible direct thrombin inhibitor, is widely used in clinical practice as a
therapeutic option due to its unique mechanism of action in comparison to other …

Background and Objectives: Anticoagulants are a well-known risk factor for gastrointestinal
bleeding (GIB). In recent years, direct oral anticoagulants (DOACs) have taken a leading …

A 68-year-old male presented with intermittent palpitations and shortness of breath for 6
months. He has past medical history of paroxysmal atrial fibrillation (AF) with CHA2DS2 …